Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets (unaudited) (Parenthetical)

v3.23.2
Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Debt Instrument [Line Items]    
Accumulated depreciation $ 98,000 $ 96,000
Common Stock, Par or Stated Value Per Share $ 0.001 $ 0.001
Common Stock Shares Authorized 500,000,000 500,000,000
Common Stock Shares Issued 385,819,422 376,074,096
Common Stock Shares Outstanding 385,819,422 376,074,096
Convertible Notes Payable [Member]    
Debt Instrument [Line Items]    
Discounts on convertible notes payable $ 45,000 $ 140,000
Convertible notes in default $ 1,814,000 $ 1,730,000